Total planned funding: $28,670,121
Clear active filters
Other USG Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Zambia | $6,132,053 |
| Mozambique | $3,880,877 |
| South Africa | $3,560,381 |
| Ukraine | $2,857,806 |
| Uganda | $1,817,265 |
| Ethiopia | $1,066,736 |
| Tanzania | $1,026,047 |
| Malawi | $957,454 |
| Lesotho | $876,161 |
| Eswatini | $767,655 |
| Zimbabwe | $745,000 |
| Cameroon | $639,387 |
| Kenya | $635,097 |
| Namibia | $492,746 |
| Ghana | $470,000 |
| Botswana | $415,000 |
| Democratic Republic of the Congo | $408,094 |
| Caribbean Region | $300,000 |
| Nigeria | $300,000 |
| Central America Region | $292,796 |
| Haiti | $250,000 |
| Rwanda | $238,118 |
| Asia Regional Program | $226,448 |
| Papua New Guinea | $195,000 |
| Dominican Republic | $100,000 |
| Côte d'Ivoire | $20,000 |
| Guyana | $0 |
| Vietnam | $0 |
| Central Asia Region | $0 |
Organizational Types
| Other USG Agency | $28,670,121 |
Program Areas
| Governance and Systems | $7,988,684 |
| Care | $7,362,421 |
| Prevention | $6,754,023 |
| Treatment | $6,098,229 |
| Testing | $466,764 |
Budget Codes
| HLAB: Laboratory Infrastructure | $5,302,651 |
| HKID: Care: Orphans and Vulnerable Children | $5,219,526 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $4,979,749 |
| HTXS: Treatment: Adult Treatment | $4,969,906 |
| HBHC: Care: Adult Care and Support | $1,767,153 |
| OHSS: Health Systems Strengthening | $1,713,862 |
| PDTX: Treatment: Pediatric Treatment | $1,128,323 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,043,973 |
| HVSI: Strategic Information | $972,171 |
| HVCT: Testing: HIV Testing and Counseling | $466,764 |
| HMBL: Biomedical Prevention: Blood Safety | $454,687 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $195,168 |
| PDCS: Care: Pediatric Care and Support | $190,063 |
| HVTB: Care: TB/HIV | $185,679 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $80,446 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| HTXD: Treatment: ARV Drugs | $0 |